Patients in Sutton Coldfield currently go unserved and have restricted access to medical cannabis treatments, including delays in doctor consultations and frequent stock shortages due to reliance on imports.
Dalgety, the UK’s first licensed EU-GMP medical cannabis cultivation and manufacturing facility, is addressing these issues by producing pharmaceutical-grade cannabis right here in the Midlands – meaning prescriptions can be fulfilled within two weeks.
For those in the Royal Town managing chronic pain, neurological conditions, or the side effects of cancer treatments, this represents a vital improvement in care and reliability.
The UK medical cannabis industry is one of the fastest-growing healthcare sectors in Europe. Dalgety is at the forefront of this growth, helping to establish the Midlands – and by extension Sutton Coldfield – as a hub for the industry.
